Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia

NCT01963598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcopenia

Interventions

DRUG: REGN1033 (SAR391786)
DRUG: placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]